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Johnson, M.D., F.A.C.C., E. JLanne O'Sullivan, R.N., G. 
Martin Mullen, .D., F.A.C.C., Diane 
F.A.C.C., Roque Pifarre, M.D., Patrick J. Scanlon, M.D., 
F.A.C.C., John A. Robinson, H.D. Loyola University 
Medical Center, Haywood, IL, 
To determine the importance of the timing of Cyclo- 
sporine initiation, we compared the 3 month postoperative 
course of OKT3 treated (Smg daily x 14 days) cardiac 
transplant pts who began Cyclosporine preoperatively 
(CYO), at 4(CY4) or at ll(CY1l) days postoperatively. Day 
4 was chosen as the earliest day so that stshilization of 
renal function would minimize Cyrl2;porine nephrotoxic- 
ity. Day 11 was chosen as the latest day to allow a- 
chievement of therapeutic Cyclosporine levels before 0KT3 
termination. Groups were similar in age, sex, type of 
heart disease, preformed anti bodies, hemodynamic support, 
donor ischemic time and concomitant immunosuppression. 
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Conclusions: 1) In OKT3 treated pts, Cyclosporine initia- 
tion at day 4 provides superior immunosuppression com- 
pared to preoperative and day 11 drug initiation. 2) The 
temporal relationship of Cyclosporine initiation to allo- 
grafting may affect rejection by producing differential 
effects on T-cell subsets. 
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: 1) OKT3 reduces the average number of rejection 
episodes during the fmt 3 months post tx but not that a i mild Ejection. 
F) During 4- 12 mos, slit frequency of pro 
IS duxeased in CAP but not significantly cF 
ssioil fin mild Ejection 
anged in OKT3. These data 
suggest that in OKT3 treated pts, increased rcjeetion surveillance is 
required following a mild rejection episode at 4-12 mos post-op. 
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Intravenous solumedrol pulse therapy (IVS) is frequently given for 
severe rejection after cardiac transplantation but has not 
previously been compared to an oral prednisone pulse and taper 
(OPT) for asymptomatic rejection (RJ) in a randomized trial. For 
moderate rejection wi 
initial discharge, 27 
cal compromise occurring after 
conse outpatients were randomized to 
return daily for 3 days of l0OOmg (I2 pts) or to take 0 
1OOmg prednisone for 3 days tapering to the previous maintenance 
dose over 14 days (15 pts). Follow-up biopsies were read ar 2 and 
4 wks without knowledge of Rx, and infections during the next 3 
months were compared for the 2 groups. 
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OPB is as effective as 
Further study will be 
for resolution of asymptomatic RJ. 
required to determine the relative 
complication rates. The higher cost and inconvenience of IVP 
may not be warranted for therapy of asymptomatic moderate 
after cardiac transplantation. 
The spontaneous long-term variability of ventricular premature 
depolarization (VPD) frequency wa, determined in 52’1 post- 
MI patients (pts) enrolled in the Cardiac Arrhythmia 
Suppression Trial (CAST). We compared the VPD frequency 
on 24 hr Holter at baseline (CAST qualification), to that 
followhg washout of encainide, flecainide or their respective 
placebos in the same pts. Only pts from CAST sites reporting 
washout Halters on at least 60% of eligible pts were included 
to minimize selection bias. The mean interval between baseline 
and washout Holters was 364 f 188 days. The mean age was 
60.3 f 9.7 yrs, the mean EF 0.40 + 0.05. Pts were divided into 
2 groups by EF (s 0.40 or > 0.40) and VPD frequencies 
compared using a paired T-test on log(VPDs/hr + 1): 
EF 5 0.40 (n= 296) 120.3 L 258.3 66.1 + 133.9 
EF OAO (n= 2w) 113.3 214.5 p 
c 0.001 
> + 89.9 f 191.2 c 0.001 
Furthermore at washout, 32.3% of pts would not have met 
CAST VPD quaIifkation criteria (2 6 VPDs/hr), and 33.2% 
would have met CAST suppression criteria (80% VP 
suppression, 90% VT suppression) on no therapy. We conclude 
that significant spontaneous VPD reduction occurs in many 
post-MI pts. This variability may have im,t>ortant implications 
to the evaluation of long-term antiarrhythmic therapy. 
